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 Summary
 Background: With increasingly aging populations, chronic obstructive pulmonary disease (COPD) is the fourth 
leading cause of death today. Emphysematous changes, an important component of the disease, 
must be determined on HRCT, either qualitatively or quantitatively. The purpose of this study 
was to evaluate features that help determine emphysematous changes and correlate them with 
respiratory function tests (RFTs).
 Material/Methods: A total of thirty COPD patients and a control group of the same size, matched for age, were 
included in the study. The mean lung parenchyma density values on inspiration and expiration, 
visual HRCT scores, and pulmonary function tests were obtained. IBM SPSS statistical software 
(version 22) was used to perform correlation analysis (Pearson’s coefficient) and the Mann-Whitney 
U test.
 Results: The most valuable RFTs for determining emphysematous changes were DLCO, FEV1, and FEV1/FVC, 
in that order. Quantitative measures of the mean lung density had the highest correlation with 
coefficient on expiration.
 Conclusions: As regards the comparison between objective and subjective density values, the HRCT-based visual 
density values are satisfactory. On the other hand, the best assessment can be performed with the 
use of mean density values on expiration. DLCO, FEV1, and FEV1/FVC were found to be valuable 
parameters in determining parenchymal changes.
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COPD is a well-defined disease. In many countries, its inci-
dence tends to rise. Because the lungs are among the early 
aging organs, in recent years, researchers have identified 
this disease primarily among the elderly. However, in the 
industrialized world, other factors, such as environmental 
pollution, stressful life, and long-term tobacco use, must be 
considered as additional causes [1,2].
In previous years, the course of the disease used to be 
determined by the forced expiratory volume in the first 
second 1 (FEV1). The reason for that was the assumption 
that the development of symptoms was due to air flow 
restrictions [3].
After developing a comprehensive database, Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) has 
defined a guideline for COPD treatment, which was addi-
tionally based on the severity of symptoms and future risk 
of aggravation [4].
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High-resolution computed tomography (HRCT) can help to 
evaluate the involved components of the lungs and sever-
ity of the disease. For instance, qualitative assessment of 
emphysematous changes has a satisfactory correlation 
with airflow obstruction [5–7]. On the other hand, objec-
tive measures of airway wall thickening also correlate well 
with pulmonary function [7–9]. Which features of specific 
lung structural abnormalities (emphysema, airway wall 
thickening, bronchiectasis, or nodularity) may provide a 
meaningful foresight to clinical course is still not clear [10].
There are some articles that compare quantitative CT visu-
al assessment with several physiological parameters; both 
measure types have a good correlation [11]. For instance, 
Kitaguchi et al. [12] used a visual evaluation of CT to phe-
notype COPD patients, which allowed for the identification 
of subgroups of patients with different clinical and func-
tional characteristics.
The aim of the present study was to evaluate the distri-
bution of emphysematous changes with qualitative visual 
scores, functional tests, and quantitative methods (HRCT) 
in patients with COPD.
Material and Methods
Thirty patients with clinically diagnosed COPD, random-
ly selected, and with stable disease were enrolled, along 
with thirty normal individuals with no clinical symptoms. 
Twenty-nine patients were male and one patient was 
female. Age ranged between 41–72 years. All patients were 
smokers, and on average, they had 35 pack-years of smok-
ing. The control group consisted of thirty healthy individu-
als (12 men, 18 women) with normal pulmonary function. 
Age ranged between 39–74 years. None of controls was a 
smoker.
HRCT scans were obtained within 2 weeks after pulmonary 
function tests. The examination was performed by with 
the Philips Ingenuity Core 128 device. Axial slices were 
obtained on deep inspiration and on expiration. Sections 
were acquired at three levels, as follows, 1 cm above the 
upper contour of the aortic arch, 1 cm below the carina, 
and 3 cm above the diaphragm dome. The matrix was 
512×512, slice thickness was 1 mm.
The kV value was 120, and mA was 80–281. A bone recon-
struction algorithm was used. Intravenous contrast agents 
were not used.
Image analysis
Observers were unaware of the clinical data and pulmo-
nary function tests, while evaluating visual data. Slices 
were evaluated by two radiologists simultaneously. Six pul-
monary parenchymal areas were evaluated from three dif-
ferent anatomic levels for each patient.
The emphysema score was calculated by multiplying sever-
ity and prevalence.
The final score was determined as the mean score of the 
two observers (radiologists).
The severity of emphysema was evaluated qualitatively 
based on four scores:
0 – No emphysema;
1 –  Low attenuation areas, 5 mm or smaller (with or with-
out vascular interruption);
2 – Low attenuation areas larger than 5 mm;
3 –  Low attenuation areas without safe lung parenchy-
ma (could be accompanied by vascular distortion and 
interruption).
The extent of emphysema was determined on four levels:
1 point: lower than 25%;
2 points: 25–50%;
3 points: 50–75%;
4 points: over 75%.
Emphysema scores were calculated by multiplying the 
severity and extent of disease for each six lung areas. After 
adding six scores of the lung fields, a total HRCT emphy-
sema visual score was obtained (ranging between 0–72 
points).
Average density values were measured for each largest lung 
area, with exclusion of central bronchovascular areas, in 
order to make possible a quantitative determination on 
deep inspiration and expiration. The average value of six 
density values was calculated for each slice.
Respiratory function tests were performed with the use of 
the Sensormedics 2400–2440 device.
Respiratory function tests
Forced expiratory volume in the first second (FEV1%), 
forced vital capacity (FVC), vital capacity (VC), total lung 
capacity (TLC), forced residual capacity (FRC), and resid-
ual volume (RV) were used as respiratory function tests. 
Normal values were determined according to the criteria of 
the American Thorax Society (ATS).
After obtaining all data, correlation analysis was per-
formed between visual CT scores, average density values, 
and respiratory function tests.
Statistical analysis
IBM SPSS statistical software (version 22) was used to per-
form correlation analysis (Pearson’s coefficient) and the 
Mann-Whitney U test.
Ethical statement
All procedures performed in studies involving human par-
ticipants were in accordance with the ethical standards of 
the institutional and national research committee and with 
the 1964 Helsinki declaration and its later amendments or 
comparable ethical standards.
Informed consent
Informed consent was obtained from all individual partici-
pants included in the study.
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Results
The mean age of patients was 48.3 years, and the mean age 
of the control group was 47.9 years.
Based on the ATS criteria, mild airway obstruction was 
found in 3 patients, moderate obstruction in 12, and severe 
obstruction in 10 patients. In 5 patients, the results were 
within normal limits. The results of the respiratory func-
tion tests, for the patient group, are shown in Table 1.
The HRCT visual score was between 12–67 points in 
patients, and between 0-5 points in the control group.
Figure 1 shows a 62-year-old patient with COPD.
HRCT visual emphysema score: 4 (for the level 1 cm below 
from the carina).
Visual emphysema score: 14 (in total).
Figure 2 shows a 41-year-old normal individual from the 
control group.
HRCT visual emphysema score: 0 (for the level 1 cm below 
from the carina).
Visual emphysema score: 0 (in total).
The mean visual score of patients and controls was 33.5 
and 2.4 points, respectively. The difference in the mean 
HRCT visual score between patients and controls was sta-
tistically significant (p<0.01).
There was a statistically significant negative correlation 
between HRCT visual scores and FEV1, FEV1/FVC, and 
DLCO values; a positive correlation between HRCT visual 
scores and FRC values was also seen (Table 2).
The correlation coefficient between HRCT visual scores 
and the mean density values on inspiration was 0.66, and 
0.76 on expiration.
The difference between the mean density values on inspi-
ration and on expiration was decreased in patients with 
airway obstruction, in comparison to the control group; 
this difference was statistically significant (Table 3).
Correlation coefficients between RFTs and density values 
on inspiration and on expiration, and HRCT visual scores 
are presented in Figure 3.
Discussion
The lungs are among the fastest aging organs. The most 
commonly used RFTs are FEV1, FVC, VC, FRC, TLC, and 
RV. After the age of 20 years, FRC and RV tend to increase, 
and FEV1, FVC, VC, and TLC tend to decrease. With increas-
ing age, mostly interstitial but also alveolar parenchymal 
changes can be determined on HRCT. Consequently, with-
out the presence of any disease, age alone can cause paren-
chymal (density) changes in the lungs. Therefore, the mean 
age of COPD patients and that of the control group was 
similar in our study.
Many studies have shown that CT is a reliable meth-
od for demonstrating parenchymal changes specific for 
RFT N Mean Standard deviation Min–Max
DLCO 17 64.29 37.78 22–140
FVC 27 64.41 24.72 31–122
VC 26 66.69 20.90 32–117
TLC 17 92.06 14.31 65–112
FRC 17 123.00 24.89 77–165
RV 17 145.71 39.73 78–247
Table 1. Mean RFT of patients
Figure 1.  A patient with COPD. Age: 62; HRCT visual emphysema 
score: 4 (for the level 1 cm below from the carina); Visual 
emphysema score: 14 (in total).
Figure 2.  A normal individual from the control group. Age: 41; HRCT 
visual emphysema score: 0 (for the level 1 cm below from 
the carina); Visual emphysema score: 0 (in total).
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emphysema. Some authors argue that CT is even more 
effective than pulmonary function tests. CT has a sensitivi-
ty of approximately 96% in diagnosing emphysema and can 
detect emphysematous areas as small as 0.5 cm2 [12–15]. 
Two main methods are currently used to determine lung 
parenchyma changes on CT. One is visual determination, 
and the other is quantitative measurement of lung paren-
chyma density.
The most important disadvantage of visual evaluation is 
that it is subjective and can be influenced by observer’s 
experience, CT window properties, and inter-observer 
variability. On the other hand, the inter-observer can be 
overestimated, as there are studies reporting that the inter-
observer variability was lower than 10%.
In practice, diagnosis of emphysema is based on a visual 
qualitative evaluation. CT criteria, such as the presence of 
low attenuation areas, pulmonary vascular interruption, 
and distortion, are used. Sakai et al. [14] defined the visual 
score method based on the severity and extent of the dis-
ease; they also found a correlation between visual scores 
and pulmonary function tests. The strongest correlation 
was found for FEV1, and FEV1/FVC values. Similar corre-
lations were reported in subsequent studies [16,17]. Some 
researchers determined the strongest correlation for DLCO 
values [18,19]. In our study, the strongest negative correla-
tion values were obtained for DLCO, FEV1, and FEV1/FVC 
values, in that order.
Two alternative methods are used for a quantitative evalu-
ation of density areas. One methods directly measures den-
sity values, and the other calculates low attenuation areas 
with density values lower than a predefined value (i.e., a 
density mask) [20–22]. Regardless of the method, a strong 
correlation between RFTs and visual scores can be deter-
mined, which is confirmed by prior studies. We chose to 
directly measure lung parenchyma density. The main dis-
advantage of evaluating lung parenchyma quantitatively is 
that the time need for examination is much longer in com-
parison to the visual determination. An optimal determina-
tion must be quantitative, but it is problematic, especially 
in time-limited institutions.
When using quantitative methods, the density mask can be 
subjective; in this case, the extent of involvement is deter-
mined by the choice of a given cut-off value. Lower cut-off 
values tend to underestimate the disease severity, whereas 
higher cut-off value tend to overestimate it. On the other 
hand, the use of direct mean density values seems more 
objective, because it is independent from the cut-off value. 
RFT İnspiration Expiration P HRCT visual correlation
DLCO –0.76 –0.90 <0.01 0.79
FRC 0.59 0.47 0.015 0.46
RV 0.46 0.40 0.07 0.49
TLC 0.39 0.18 0.13 0.17
VC –0.24 –0.54 0.27 –0.50
FVC –0.33 –0.59 0.104 –0.57
FEV1 –0.63 –0.89 <0.01 –0.84
FEV1/FVC –0.65 –0.88 <0.01 –0.80
Table 2. The relation between RFT values and mean density, visual HRCT score of patients .
Patients Control
U value P
Mean Std dev. Mean Std dev.
Inspiration 853.97 24.04 890.90 28.82 49.0 <0.01
Expiration 860.44 50.29 696.08 59.37 9.0 <0.01
















Figure 3.  Correlation coefficients between RFTs and density values on 
inspiration and expiration as well as HRCT visual scores.
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Because of these reasons, a direct measurement of density 
values was chosen in this study.
In the presence of airway obstruction, expiratory CT 
evaluation is based on the fact that some amount of air is 
trapped in the lungs. Lung density rises significantly on 
expiration, but in the case of airway obstruction, this effect 
is limited. There is a significant difference between inspira-
tory and expiratory density values, and this difference is 
negatively correlated with the severity of airway obstruc-
tion; this indicates that smaller amounts of air are moving 
on inspiration and expiration [23,24].
When the evaluation was performed on inspiration, the 
mean lung density values were within the 95% confidence 
interval in most patients, but this situation was reversed 
on expiration. Thus, expiration CT is more sensitive for 
evaluating airway obstruction. Our results were concord-
ant with those found in the literature.
The main limitation of our study was a relatively low num-
ber of patients and controls, but this can be compensated 
by the clear results that were obtained. It is unlikely that 
the results would be significantly different, if a larger sam-
ple had been used.
Conclusions
Based on the results shown in Figure 1, DLCO is the best 
indicator of emphysematous parenchyma changes, and is 
closely followed by FEV1 and FEV1/FVC. However, a strong 
correlation was not found with respect to other RFTs. As 
regards the comparison between the objective and subjec-
tive density values, HRCT visual density values are satis-
factory. On the other hand, the best assessment can be per-
formed with mean density values on expiration.
According to the results obtained in this study, RFTs other 
than FEV1 and FEV1/FVC cannot be used as indicators of 
emphysematous parenchyma changes in COPD (namely, 
vital capacity (VC), total lung capacity (TLC), forced residu-
al capacity (FRC) and residual volume (RV)).
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